SENS insider trading histrythey know what they are doing. AMEX:SENS
history always tells you people's behavior has its reason.
SENS trade ideas
overbought city across penny stock sectors, be careful traders!penny stock market has been dead recently, will continue this way for the rest of the year in my opinion. people are buying bluechip/more well known companies now. this is why i tell all my students that penny stocks are cheap for a reason, demand is low. you will rarely ever see a penny stock hold gains. unless its an amazing company with great fundamentals, that's hard to find on stocks under 10 though!
please dont forget to like and follow if you enjoy my ideas!
$SENS Double bottom reversal?Looks like SENS has touched $2.42 area for the second time and could be the signal for a possible bullish reversal. If it does reverse just know this stock likes to lose its gains pretty quickly so don't be greedy. I believe this is a perfect entry to go LONG. We are waiting on FDA approval that will probably gap us up back to the $5 range.
SENS Elliot Wave analysisIt looks like wave 2 has completed for SENS. They had a conference today march 9th about some things that were already known to us, but they made some things more clear. Quick summary of this conference:
- Accuracy of the current device is best in class with a MARD of 8.5%
- Medicare National Coverage as of Jan 1, 2021:
- Avg "Supply Cost" (I assume this is for the hardware and consumables) : $1571
- CPT Code 0446T (device insertion) $1,916 average payment
- CPT Code 0448T (device removal and insertion) $1,926 average payment
- Ascencia's commercial world wide investment in Senseonics product marketing is expected to be $30M-$80M per year over 5 years (this is where they got the $250M in the previous conference) and expect the US Ascencia personnel assigned to Senseonics to be in the 80-160 range.
- Eversense is Ascencia's first CGM product and they have exclusive rights to the sales and distribution.
Product Pipeline:
2021+ : Eversense 180 and iCGM/interoperability (integrate with insulin pumps)
2023 : Eversense 365, 1 calibration/week, optional FGM (flash glucose monitoring - no transmitter needed)
2024 : Freedom System, FGM, entire diabetes spectrum covered out to T2 non-insulin using patients.
(credits for this summary to ww.reddit.com/r/senseonics/comments/m18cxq/sens_hc_wainwright_conference_takeaways/)
I'm now looking for a 5 structure to the upside for a wave 3.
Pricetarget for wave 3 is around $10.
How long this will take I'm not sure.
$SENS Possible bullish pattern if takeout 4.17 targeting 7.83 Nice rejection from the green cloud base . Strong resistance at 3.73 and 4.17 if can break out 4.17 then possible targeting ATH at 5.5 then 6.97 and 7.83 but it may take some time .. STOP AT 2.5
SENS wedge vs momentumI see a wedge in a downtrend. However, the momentum suggests there could be a reversal. Breakout on Monday?
SENS Showing a very bullish trendLooks like a clear flag forming at a strong support line. Let me know what you think, this is my first shared chart.
Clearly not financial advise.
$SENS Bullish candlesticks pattern targeting 6.2 and 8.3ATH was at 5.3 . Strong resistance at 4.25 . above it will see ATH then above it goals will be 6.2 - 7.2 - 8.3 which almost double current price. Stop at 2.8 for long view! . Worth to say, this name jumped from 0.4 to 4 during A month!! which means its high risky trade too.
Squeeze forming. Could be PUMP again very soonAfter first money of first PUMP is out. Second one firing. Good company essentials and new product in the pipeline with Social security insurance coverage. Waiting to get confirmation about their financials tomorrow after market closing. Ready for next similar angle up before end of March already.
SENS potential trendsBuddy and I found these potential trends in SENS. It's lower due to the recents news around the FDA approval. But I could see both potential trends happening based on the past. Who knows.
This stock is definitely on my watchlist to test it out depending on what further info comes out.
Almost at the end of Wave 4. Sideway move expectedWave 3 correction to Wave 4. Hit Fib 0.61 retracement level. Could it be the end of Wave 4?
Might see price lingering within $3.29-2.99. Until it bounces off $3.29 and shows bullish sign, currently a downward momentum.
Stop Loss $2.4. Profit $4.2. $4.2 is key resistance level. Once breakout then Fib Ext 61.8% at $5.25.
Time to buy the DipThe company and its goals are still the same.
I cannot explain why but a movement before a earnings report is often negative, and raises shortly before the earnings report is reviled.
According to the NASDAQ holders list, some of the large like the rest of the market are selling there stocks but nothing substantial, and the majority of them are still holding.
I'm bullish on this stock. I believe that it would reach new heights in the coming month.
SENS Elliot Wave analysisSENS is a medical tech company focused on the design and development of glucose monitoring products designed to help people with diabetes.
Pricetarget wave 2 correction: $3.00
Pricetarget wave 3: $12-24.
The pricetarget of wave 3 will likely be driven by the US FDA approval coming march 2021. Hype will most likely drive the early stages of wave 3. Hopefully this hype will be backed up by fundamental growth of the company where it starts to make profits and scale in the market. If they don't get FDA approval this stock will most likely fall. High risk high reward play.
~slippe
SENS - Bull flagSENS looks like its going to continue bullish this week. MACD reversal, oversold on RSI, still gaining volume.
Channel Trend for SENSPersonally analyze that it will continue to go up, if not, it will go sideways and move up in the next 2-3 days..
$SENSSenseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes primarily in Europe. Its products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with diabetes for a period of up to 90 and 180 days. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.
SENS Breakout Price Targets and ResistancesSENS still has some room to run. The price targets are based off of the extended support and resistances of the run up to previous all time highs.
Pull backs within the up trend can be expected to retrace to underlying lines drawn when price moves above.
SENS testing resistance. SENS is testing resistance trading at the line of resistance. We need a candle above the line of resistance to break it and if it does we can see a nice move up. RSI is in the overbought territory, and is heading higher up. MACD looks to be open green which is bullish.
